Bs. Gostout et al., CERVICAL-CANCER IN OLDER WOMEN - A MOLECULAR ANALYSIS OF HUMAN-PAPILLOMAVIRUS TYPES, HLA TYPES, AND P53 MUTATIONS, American journal of obstetrics and gynecology, 179(1), 1998, pp. 56-61
OBJECTIVE: The purpose of this study was to evaluate cervical cancers
in older women to determine whether they differed from tumors in young
er women with respect to human papillomavirus types, frequencies of p5
3 mutations, and presence of a proposed high-risk HLA-DR2 haplotype. S
TUDY DESIGN: Cervical tissue was obtained from women undergoing surgic
al treatment of in situ or invasive carcinoma of the cervix. Viral and
genomic deoxyribonucleic acid was extracted. The presence of human pa
pillomavirus deoxyribonucleic acid was detected by polymerase chain re
action amplification. Viral subtypes were assigned by means of a combi
nation of type-specific amplification and automated sequencing of the
L1 region. The presence of p53 mutations was evaluated by direct seque
ncing of exons 5 through 9. The HLA-DR locus was screened for the pres
ence of the high-risk DRB11501 allele by means of selective polymeras
e chain reaction amplification followed by agarose gel electrophoresis
of HLA-DR2 types. RESULTS: Tumors from 39 women 62 to 85 years old we
re analyzed. Tumors from 104 younger women formed a reference group. H
uman papillomavirus 16 was found in 41% and 54% and human papillomavir
us 18 was found in 10% and 12% of the tissue samples from older and yo
unger women, respectively. The overall distributions of human papillom
avirus types did not differ statistically between the groups. One of t
he 25 older patients tested had a p53 mutation. This tumor also had a
positive test result for human papillomavirus 18. The DR1501 allele w
as present in 33% of the older patients and 28% of the younger patient
s. The expected frequency of this allele in white Americans is 19.8%.
The increased frequency of this allele among both older and younger wo
men with cervical cancer was statistically significant (P < .05). CONC
LUSIONS: We hypothesized that cervical cancer in older women might dif
fer from that in younger women with respect to human papillomavirus ty
pes, natural host immunity, or the frequency of nonviral origins of th
e cancer. The findings show, however, that tumors from older women are
extremely similar to those from younger women with respect to the hum
an papillomavirus types present and the infrequent occurrence of p53 m
utations. In addition we found that an HLA-DR allele that is associate
d with a risk of cervical cancer in younger women is also associated w
ith risk in older women. These findings are most consistent with a mod
el similar to that in younger women but with an unusually long latency
for the transforming effect of the virus in some hosts.